Neumora (NMRA) - Forvard narx/daromad multiplikatori

Neumora Corp (NMRA) - korporativ logo

Neumora Therapeutics (NMRA) uchun eng yaqin o'sish katalizatori uning innovatsion antidepressanti uchun II bosqich sinovlari natijalari bo'ladi. Forward P/S koeffitsiyenti ushbu tendentsiyani vizuallashtiradi, bunda belgisi metrikaning joriy holatini ko'rsatadi. Biznesning rivojlanishi biomarker platformalarining aniqligiga va tartibga soluvchi organlarning tasdig'iga bog'liq. Strategiyaning muvaffaqiyati mavjud R&D kapitaliga va shizofreniya davolash usullarining tasdiqlanishiga asoslangan.

neumoratx.com - NMRA Sotuvga nisbatan forvard narx (davr: 04.07.2022 - 16.11.2026)

Neumora Therapeutics (NMRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning fundamental tahlili:NMRA (Neumora Therapeutics, Inc.)
Neumora Corp original mahsuloti

Biznes sifatini tekshirishda investor kelajakdagi o'sish sur'atlari uchun to'langan premium miqdorini aniqlash uchun joriy bozor kapitalizatsiyasining kutilayotgan daromadga nisbatini baholaydi. Ushbu forward P/S baholash ko'rsatkichi prognoz qilingan savdolarga nisbatan bozor multiplikatorini aks ettiradi, bu esa Neumora Therapeutics (NMRA) uchun aniqlik neurobiologiyasiga bo'lgan elastik bo'lmagan talab va uning genetik molekulalarni tanlash platformasining noyobligi tufayli yuqori baholangan premium qiymatni tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|SCLX: Forvard P/S multiplikatori|TVGN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ACOG (Alpha Cognition Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori cogrx.com (CGTX)|Narxning prognoz qilingan daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cassava Sciences|Forvard P/S multiplikatori ASRT (Assertio Holdings)|COYA - Forvard narx/daromad multiplikatori|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori